IL159494A0 - 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity - Google Patents

6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity

Info

Publication number
IL159494A0
IL159494A0 IL15949402A IL15949402A IL159494A0 IL 159494 A0 IL159494 A0 IL 159494A0 IL 15949402 A IL15949402 A IL 15949402A IL 15949402 A IL15949402 A IL 15949402A IL 159494 A0 IL159494 A0 IL 159494A0
Authority
IL
Israel
Prior art keywords
phosphonomethoxy
antiviral activity
pyrimidine derivatives
alkoxy pyrimidine
alkoxy
Prior art date
Application number
IL15949402A
Other languages
English (en)
Original Assignee
Acad Of Science Czech Republic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acad Of Science Czech Republic filed Critical Acad Of Science Czech Republic
Publication of IL159494A0 publication Critical patent/IL159494A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15949402A 2001-06-29 2002-06-28 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity IL159494A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30221201P 2001-06-29 2001-06-29
PCT/CZ2002/000038 WO2003002580A1 (en) 2001-06-29 2002-06-28 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity

Publications (1)

Publication Number Publication Date
IL159494A0 true IL159494A0 (en) 2004-06-01

Family

ID=23166777

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15949402A IL159494A0 (en) 2001-06-29 2002-06-28 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
IL159494A IL159494A (en) 2001-06-29 2003-12-22 Derivatives 6 – '2– (phosphonomethoxy) alkoxy pyrimidine with antiviral activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159494A IL159494A (en) 2001-06-29 2003-12-22 Derivatives 6 – '2– (phosphonomethoxy) alkoxy pyrimidine with antiviral activity

Country Status (21)

Country Link
US (2) US6818633B2 (cs)
EP (1) EP1406911B1 (cs)
JP (1) JP4545434B2 (cs)
KR (1) KR100891366B1 (cs)
CN (1) CN1329404C (cs)
AP (1) AP1622A (cs)
AU (1) AU2002315625B2 (cs)
BR (1) BRPI0210746B8 (cs)
CA (1) CA2452036C (cs)
CZ (1) CZ297267B6 (cs)
EA (1) EA006020B1 (cs)
ES (1) ES2564144T3 (cs)
HU (1) HU230519B1 (cs)
IL (2) IL159494A0 (cs)
MX (1) MXPA04000138A (cs)
NO (2) NO333788B1 (cs)
NZ (1) NZ530685A (cs)
PL (1) PL207187B1 (cs)
TR (1) TR200302288T2 (cs)
WO (1) WO2003002580A1 (cs)
ZA (1) ZA200400236B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004031115D1 (de) * 2003-06-16 2011-03-03 Acad Of Science Czech Republic Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
EP1831235B1 (en) 2004-12-16 2013-02-20 The Regents of The University of California Lung-targeted drugs
US20060211650A1 (en) * 2004-12-16 2006-09-21 Forest Laboratories, Inc. Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
AU2006272521A1 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of HIV
US7473683B2 (en) 2005-09-14 2009-01-06 The Board Of Trustees Of The Leland Stanford Junior University Nonpolar thymidine analogs
WO2007047405A1 (en) * 2005-10-13 2007-04-26 Allergan, Inc. Ddc compositions
FR2908133B1 (fr) * 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
US20140073607A1 (en) * 2011-05-10 2014-03-13 Okapi Sciences Nv Compounds for use in the treatment of feline retroviral infections
LT2970346T (lt) 2013-03-15 2018-11-26 The Regents Of The University Of California Acikliniai nukleozido fosfonato diesteriai
CN104119385B (zh) * 2014-07-24 2017-04-05 廖国超 核苷类似物的磷酸酯前药及其应用
CN106795188B (zh) 2014-09-15 2021-02-09 加利福尼亚大学董事会 核苷酸类似物
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs
WO2019206907A1 (en) * 2018-04-23 2019-10-31 Centre National De La Recherche Scientifique New antiviral acyclonucleoside analogues
IL318465A (en) 2022-07-21 2025-03-01 Antiva Biosciences Inc Compositions and dosage forms for the treatment of HPV infection and HPV-induced neoplasia
CN117430644B (zh) * 2023-10-24 2025-08-01 合肥工业大学 一种钴配合物的制备及用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263951B1 (en) 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS264222B1 (en) 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
CA2001715C (en) 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
CA2297294C (en) * 1989-05-15 2005-11-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Phosphonomethoxymethylpurine/pyrimidine derivatives
MY104575A (en) 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5302585A (en) 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
CZ285420B6 (cs) 1990-04-24 1999-08-11 Ústav Organické Chemie A Biochemie Avčr N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití
WO1992001698A1 (en) 1990-07-19 1992-02-06 Beecham Group Plc Antiviral phosphono-alken derivatives of purines
EP0468119A1 (en) 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
DE10399025I2 (de) 1990-09-14 2007-11-08 Acad Of Science Czech Republic Wirkstoffvorläufer von Phosphonaten
US5208221A (en) 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
CZ284678B6 (cs) 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
EP0531597A1 (en) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
DE69218968T2 (de) 1991-10-11 1997-10-09 Inst Of Organic Chemistry And Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
EP0618214A1 (en) 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Unsaturated phosphonate derivatives of purines and pyrimidines
BR9407510A (pt) 1993-09-17 1997-01-07 Gilead Sciences Inc Análogos de nucleotideo
US5977061A (en) 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use

Also Published As

Publication number Publication date
AP2004002953A0 (en) 2004-03-31
CN1533397A (zh) 2004-09-29
AP1622A (en) 2006-06-16
HU230519B1 (hu) 2016-10-28
US20050038058A1 (en) 2005-02-17
PL366852A1 (en) 2005-02-07
NO20131091L (no) 2004-02-24
WO2003002580A1 (en) 2003-01-09
HUP0400345A3 (en) 2007-05-29
PL207187B1 (pl) 2010-11-30
KR20040027521A (ko) 2004-04-01
BRPI0210746B8 (pt) 2021-05-25
HUP0400345A2 (hu) 2004-09-28
NZ530685A (en) 2006-09-29
NO20035797L (no) 2004-02-24
US6818633B2 (en) 2004-11-16
US20030109499A1 (en) 2003-06-12
AU2002315625B2 (en) 2008-05-01
NO335725B1 (no) 2015-02-02
EP1406911B1 (en) 2016-01-06
BR0210746A (pt) 2004-07-20
CZ297267B6 (cs) 2006-10-11
WO2003002580A8 (en) 2003-01-30
CA2452036A1 (en) 2003-01-09
ES2564144T3 (es) 2016-03-18
CA2452036C (en) 2009-09-29
MXPA04000138A (es) 2005-06-06
JP2005511490A (ja) 2005-04-28
EP1406911A1 (en) 2004-04-14
NO333788B1 (no) 2013-09-16
BRPI0210746A8 (pt) 2018-07-10
CZ2004142A3 (cs) 2004-05-12
BRPI0210746B1 (pt) 2018-09-18
EA200400117A1 (ru) 2004-08-26
TR200302288T2 (tr) 2004-12-21
CN1329404C (zh) 2007-08-01
JP4545434B2 (ja) 2010-09-15
ZA200400236B (en) 2004-08-18
KR100891366B1 (ko) 2009-04-02
EA006020B1 (ru) 2005-08-25
IL159494A (en) 2008-06-05

Similar Documents

Publication Publication Date Title
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
PL363866A1 (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
IL159494A0 (en) 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
GB0112617D0 (en) Antiviral nucleoside derivatives
AU6931701A (en) Pyrimidine derivatives
IL161619A0 (en) Quinazoline derivatives as antitumor agents
IL161620A0 (en) Quinazoline derivatives as antitumor agents
DK3808743T3 (da) HIV-hæmmende pyrimidin-derivater
IL159023A0 (en) 4' -substituted nucleosides
DE60234376D1 (de) 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
EP1363705A4 (en) COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
EG24848A (en) Preparation of aminopyrimidine compounds
EP1458687A4 (en) pyrimidine
IL154418A0 (en) Pyrimidine compounds and their use
GB0105337D0 (en) C2,5'-disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and their different uses
AU2002362806A1 (en) Pyrimidine derivatives
AU2792102A (en) Pyrimidine derivatives
GB0112802D0 (en) Pyrimidine derivatives
IL160433A0 (en) 4"-deoxy-4"-(s)-amino avermectin derivatives
EG22778A (en) Substituted n-benzoyl-n'-(tetrazolylphenyl)-ureas
GB0608741D0 (en) Supramolecular compounds and their use as antitumour and antiviral agents
EP1374911A4 (en) MEANS FOR MEASURING THE METABOLIZABILITY OF PYRIMIDINE
GB0119477D0 (en) Pyrimidine derivatives
HK1063430A (en) 6-[2-(phosphonomethoxy)alkoxy]pyrimidine derivatives having antiviral activity
GB0112807D0 (en) Pyrimidine derivatives

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted